Gli altri portali
Notizie
Comunicati Stampa
Social News
Offerte di Lavoro
Comunicati Stampa
Sezioni
Toggle navigation
Prima pagina
Elenco
Nuovo account
Inserimento
Pannello di controllo
Modifica password
Salute e Benessere
Seleziona Categoria
Tutte le Categorie
Agricoltura
Ambiente
Arte e Cultura
Cibi e Bevande
Economia
Editoria e Media
Elettronica
Energia
Fiere ed Eventi
Industria
Information Technology
Internet
Istruzione e Formazione
Moda
Non Profit
Politica e Istituzioni
Salute e Benessere
Scienza e Tecnologia
Servizi
Società
Spettacolo
Sport
Telecomunicazioni
Trasporti
Turismo
Varie
Italiano
Inglese
Spagnolo
Frost & Sullivan published AI Medical Imaging Bluepaper and FOSUN AITROX is…
AI can play a crucial role in medical diagnostics. AI models can improve the sensitivity, specificity, and other key parameters of disease diagnoses, particularly in areas such as image enhancement, lesion identification, 3D reconstruction, and automated reporting. As algorithm models continue to improve, they can identify abnormalities that are indiscernible to the naked eye. In certain specific disease diagnoses, AI has achieved accuracy comparable to that of highly experienced medical…
PR Newswire
22/08/2024
Orion Corporation: Managers' transactions – Satu Ahomäki
ORION CORPORATIONMANAGERS' TRANSACTIONS22 AUGUST 2024 at 10.30 EEST Orion Corporation: Managers' transactions – Satu Ahomäki Orion Corporation has received the following disclosure under Market Abuse Regulation (EU) No 596/2014, regarding transactions with shares and linked securities in Orion Corporation made by managers and their closely associated persons.Orion Oyj - Managers' Transactions____________________________________________Person subject to the notification...
Nasdaq GlobeNewswire
22/08/2024
Regarding rumors of an imminent approval of lecanemab in Great Britain…
For further information, please contact: Oskar Bosson, VP Communications and IRE-mail:
[email protected]
: +46 70 410 71 80 For further information, please contact: Oskar Bosson, VP Communications and IR E-mail:
[email protected]
: +46 70 410 71 80 About BioArctic ABBioArctic AB (publ) is a Swedish research-based biopharma company focusing on innovative treatments that can delay or stop the progression of neurodegenerative diseases. The company invented...
PR Newswire
22/08/2024
Invitation and registration for Essity's Capital Markets Day on December 3, 2024
Use the link below to register your participation no later than October 1. The number of seats is limited, and priority will therefore be given to institutional investors, financial analysts and financial media. Use the link below to register your participation no later thanOctober 1. The number of seats is limited, and priority will therefore be given to institutional investors, financial analysts and financial media. Register for Essity's Capital Markets Dayhere The Capital...
PR Newswire
22/08/2024
Bavarian Nordic Announces First Half 2024 Results
COPENHAGEN, Denmark, August 22, 2024– Bavarian Nordic A/S (OMX: BAVA) announced today its interim financial results and business progress for the first half of 2024 and released its financial calendar for 2025. Revenue for the first half was DKK 2,259 million, and the operating profit (EBITDA) was DKK 441 million.Revenue from travel health increased by 15% to DKK 1,119 million and revenue from public preparedness was DKK 1,024 million, which is in line with the Company's expectations...
Nasdaq GlobeNewswire
22/08/2024
Crossject to Present at the H.C. Wainwright 26th Annual Global Investment…
Press ReleaseDijon, France August 22, 2024 07:30 CET -- Crossject (ISIN: FR0011716265; Euronext: ALCJ), a specialty pharma companydeveloping medicines for emergency situations harnessingits award-winning needle-free auto-injector ZENEO®,announced that it will present virtually and participate in one-on-one investor meetings at the H.C. Wainwright 26th Annual Global Investment Conference, taking place at the Lotte New York Palace Hotel in New York City fromSeptember 9th-11th,...
Nasdaq GlobeNewswire
22/08/2024
Interim Report Q2 2024: Strong execution leading to 5% organic growth and margin…
HighlightsGN executed strongly across the three divisions resulting in 5% organic revenue growth for the GroupThe Hearing division continued to gain significant market share leading to 10% organic revenue growth, resulting in 5.3 percentage point increase in the divisional profit margin supported by synergies and the successful ReSound Nexia roll-outThe Enterprise division continued its focused execution leading to -3% organic revenue growth in a stabilizing market. The divisional...
Nasdaq GlobeNewswire
22/08/2024
Brains Bioceutical Set to Achieve One of the World's First CEP for Cannabidiol…
Advancing Pharmaceutical Innovation: Brains Bioceutical's CEP Certification will Streamline Cannabinoid Drug Development, Inspired by Jazz Pharmaceuticals' CBD-Based Epilepsy Drug and 2024 $1.4 Billion Revenue Projection The CEP confirms that BBC's CBD meets European Pharmacopoeia (Ph. Eur.) standards, a crucial endorsement for pharmaceutical manufacturers in Europe, Canada, Australia, Japan, and the US. This certification streamlines regulatory processes, ensuring high quality,...
Nasdaq GlobeNewswire
22/08/2024
Jazz Pharmaceuticals to Participate in Upcoming September Investor Conferences
Bank of America Global Healthcare Conference on Wednesday, September 18, 2024 Bank of America Global Healthcare Conference onWednesday, September 18, 2024 Audio webcasts of the fireside chats will be available via the Investors section of the Jazz Pharmaceuticals website athttps://investor.jazzpharma.com/investors/events-presentations. A replay of the webcasts will be archived on the website for 30 days. About Jazz Pharmaceuticals Jazz Pharmaceuticals plc (Nasdaq: JAZZ) is a...
PR Newswire
21/08/2024
PI3K Inhibitors Market to Observe Stunning Growth During the Study Period…
Key Takeaways from the PI3K Inhibitors Market Report Key Takeaways from the PI3K Inhibitors Market Report Discover which therapies are expected to grab the PI3K inhibitors market share @ PI3K Inhibitors Market Report PI3K Inhibitors Market Dynamics The PI3K inhibitors market is characterized by dynamic growth and a rapidly evolving landscape driven byadvancements in cancer research, increasing incidence of cancer,and rising awarenessabout targeted therapies. This market...
PR Newswire
21/08/2024
Bavarian Nordic Receives 440,000 Dose Contract to Supply Smallpox and Mpox…
The order was anticipated as part of the 2024 guidance and has no impact on the remaining 2024/25 capacity for the Company's smallpox and mpox vaccine.COPENHAGEN, Denmark, August 21, 2024– Bavarian Nordic A/S (OMX: BAVA) today announced the award of a contract of 440,000 doses to supply its MVA-BN ®smallpox/mpox vaccine to an undisclosed European country. Paul Chaplin, President & CEO of Bavarian Nordic, said: “Since the last mpox outbreak in 2022/23 Bavarian Nordic has...
Nasdaq GlobeNewswire
21/08/2024
Astrocytoma Treatment Drug Market to Witness Upsurge in Growth During the Study…
Key Takeaways from the Astrocytoma Market Report Key Takeaways from the Astrocytoma Market Report Discover which therapies are expected to grab the major astrocytoma market share @ Astrocytoma Market Report Astrocytoma Overview Astrocytoma is a type of cancer that originates in the astrocytes, star-shaped cells in the brain and spinal cord that support nerve cells. Symptoms of astrocytoma vary depending on its location and size but commonly include headaches, seizures, memory...
PR Newswire
21/08/2024
Complement Inhibitors Market is Predicted to Exhibit Remarkable Growth During…
Key Takeaways from the Complement Inhibitors Market Report Key Takeaways from the Complement Inhibitors Market Report Discover which therapies are expected to grab the complement inhibitors market share @ Complement Inhibitors Market Report Complement Inhibitors Market Dynamics The complement inhibitors market has been witnessing significant growth, driven by the increasing prevalence of autoimmune and inflammatory diseases. Asresearch and development in immunology advance,...
PR Newswire
21/08/2024
WuXi Biologics Reports Solid 2024 Interim Results
Financial Highlights Financial Highlights Business Highlights Management Comment Dr.Chris Chen, CEO of WuXi Biologics, stated, "Amid a dynamic macroeconomic and geopolitical environment, our business has demonstrated strong resilience. This is attributed to our unique CRDMO business model which we believe is the most efficient for our industry, as well as the successful implementation of our 'Follow and Win the Molecule' strategies. In the first half of 2024, we added 61 new...
PR Newswire
21/08/2024
Orion Corporation: Managers' transactions – Niclas Lindstedt
ORION CORPORATIONMANAGERS' TRANSACTIONS21 AUGUST 2024 at 18.45 EEST Orion Corporation: Managers' transactions – Niclas Lindstedt Orion Corporation has received the following disclosure under Market Abuse Regulation (EU) No 596/2014, regarding transactions with shares and linked securities in Orion Corporation made by managers and their closely associated persons.Orion Oyj - Managers' Transactions ____________________________________________ Person subject to the notification...
Nasdaq GlobeNewswire
21/08/2024
BCMA-Targeted Therapies Market to Witness Upsurge in Growth During the Study…
Key Takeaways from the BCMA-Targeted Therapies Market Report Key Takeaways from the BCMA-Targeted Therapies Market Report Discover which therapies are expected to grab the BCMA-targeted therapies market share @ BCMA-Targeted Therapies Market Report BCMA-Targeted Therapies Market Dynamics The BCMA-targeted therapies market has witnessed significant growth and interest, primarily driven by their promising potential in treating multiple myeloma. The advent of BCMA-targeted...
PR Newswire
21/08/2024
Microsampling Devices Market worth $135 million by 2029 driven by Shifting…
Browse in-depth TOC on "Microsampling Devices Market" Browse in-depth TOC on "Microsampling Devices Market" 292 - Tables 42 - Figures 268 - Pages Tasso, Inc.: Market Leader in Microsampling Devices Tasso, Inc. (US) is a leading player in the microsampling devices market, holding the largest market share in 2023. Since its inception, Tasso's products have been widely used in pharmaceutical clinical trials and across many hospitals in the US. The company leverages both...
PR Newswire
21/08/2024
Toffeln Announces Acquisition of Avail Medical
The collaboration between Toffeln and Avail Medical is founded on a shared commitment to improving the wellbeing and efficiency of healthcare workers. "This union represents a great step forward in our mission to support healthcare professionals with the best possible products and services," said Ben Turner, Managing Director of Toffeln. "By bringing together our complementary strengths, we are poised to enabling better healthcare for staff as well as patients." The…
PR Newswire
21/08/2024
Ultrasound Market to be Worth $18.07 billion by 2031 - Exclusive Report by…
The report offers a competitive landscape based on an extensive assessment of product offerings, geographical presence, and key growth strategies adopted by prominent market players over the past three to four years. The key players profiled in the ultrasound market study are GE Healthcare Technologies Inc. (U.S.), Konica Minolta, Inc. (Japan), Koninklijke Philips N.V. (Netherlands), Siemens Healthineers AG (Germany), Canon Inc. (Japan), Esaote S.p.A (Italy), Shenzhen Mindray Bio-Medical…
PR Newswire
21/08/2024
UTime Limited Announces Ambitious AI Health Strategy and Strategic Collaboration
Additionally, UTime intends to launch a variety of products focusing on smart detection of key health indicators, such as heart rate and sleep monitoring devices. Additionally, UTime intends to launch a variety of products focusing on smart detection of key health indicators, such as heart rate and sleep monitoring devices. Hengcong Qiu, Chairman of UTime, commented, "We believe that our strategic cooperation with Dr.Ehud Baronand our AI-enabled healthcare initiatives will spearhead key...
PR Newswire
21/08/2024
Hain Celestial Unlocks Fuel For Growth Through Productivity and Sourcing, Cash…
Introduced in September 2023, Hain Reimagined outlined comprehensive plans to transform the company into a globally integrated enterprise to drive scale and deliver long-term shareholder value. A key aspect of the strategy is unlocking fuel for growth, which is comprised of revenue growth management, cash management and operational efficiencies to fund the transformation. Introduced inSeptember 2023, Hain Reimagined outlined comprehensive plans to transform the company into a globally...
PR Newswire
21/08/2024
OKYO Pharma Announces Chairman Acquires Shares
LONDON and NEW YORK, Aug.21, 2024(GLOBE NEWSWIRE) -- OKYO Pharma Limited (NASDAQ: OKYO), a clinical-stage biopharmaceutical company developing innovative ocular therapies for the treatment of inflammatory dry eye disease (DED), a multi-billion-dollar market, and anterior ocular segment diseases including neuropathic corneal pain (NCP), an ocular condition associated with pain but without an FDA approved therapy, announced today that it has been notified that Panetta Partners Limited, an...
Nasdaq GlobeNewswire
21/08/2024
Hemodynamic Monitoring Devices Market to Reach $1.9 Billion, Globally, by 2033…
Request Sample of the Report on Hemodynamic Monitoring Devices Market Forecast 2033 -https://www.alliedmarketresearch.com/request-sample/A122626 Prime determinants of growth The hemodynamic monitoring market is being propelled by several key drivers such as technological advancements such as the development of minimally invasive devices and wearable sensors are enhancing patient comfort and providing real-time data. The increasing prevalence of cardiovascular diseases and...
PR Newswire
21/08/2024
SciBase changes Certified Adviser to Carnegie Investment Bank AB (publ)
For additional information, please contact:Pia Renaudin, VD, tel. +46732069802, e-mail:
[email protected]
Advisor (CA): For additional information, please contact: Pia Renaudin, VD, tel. +46732069802, e-mail:
[email protected]
Certified Advisor (CA): Vator Securities Tel: +46 8 580 065 99 Email:
[email protected]
About SciBase: SciBase is a global medical technology company, specializing in early detection and prevention in dermatology. SciBase...
PR Newswire
21/08/2024
Altri Comunicati
